90 related articles for article (PubMed ID: 18328143)
21. Physical, psychosocial and economic impact of rheumatoid arthritis: a pilot study of patients seen at a tertiary care referral centre.
Aggarwal A; Chandran S; Misra R
Natl Med J India; 2006; 19(4):187-91. PubMed ID: 17100104
[TBL] [Abstract][Full Text] [Related]
22. Canadian estimates of health care utilization costs for rheumatoid arthritis patients with and without therapy with biologic agents.
Ohinmaa AE; Thanh NX; Barnabe C; Martin L; Russell AS; Barr SG; Maksymowych WP
Arthritis Care Res (Hoboken); 2014 Sep; 66(9):1319-27. PubMed ID: 24470178
[TBL] [Abstract][Full Text] [Related]
23. Costs of rheumatoid arthritis in France: a multicenter study of 1109 patients managed by hospital-based rheumatologists.
Guillemin F; Durieux S; Daurès JP; Lafuma A; Saraux A; Sibilia J; Bourgeois P; Sany J
J Rheumatol; 2004 Jul; 31(7):1297-304. PubMed ID: 15229947
[TBL] [Abstract][Full Text] [Related]
24. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls.
Gabriel SE; Crowson CS; Campion ME; O'Fallon WM
J Rheumatol; 1997 Jan; 24(1):43-8. PubMed ID: 9002009
[TBL] [Abstract][Full Text] [Related]
25. Medical care costs of patients with rheumatoid arthritis during the prebiologics period in Japan: a large prospective observational cohort study.
Tanaka E; Inoue E; Mannalithara A; Bennett M; Kamitsuji S; Taniguchi A; Momohara S; Hara M; Singh G; Yamanaka H
Mod Rheumatol; 2010 Feb; 20(1):46-53. PubMed ID: 19821162
[TBL] [Abstract][Full Text] [Related]
26. Radiographic damage in rheumatoid arthritis correlates with functional disability but not direct medical costs.
Clarke AE; St-Pierre Y; Joseph L; Penrod J; Sibley JT; Haga M; Genant HK
J Rheumatol; 2001 Nov; 28(11):2416-24. PubMed ID: 11708412
[TBL] [Abstract][Full Text] [Related]
27. Modelling the effect of function and disease activity on costs and quality of life in rheumatoid arthritis.
Kobelt G; Lindgren P; Lindroth Y; Jacobson L; Eberhardt K
Rheumatology (Oxford); 2005 Sep; 44(9):1169-75. PubMed ID: 15956093
[TBL] [Abstract][Full Text] [Related]
28. Analysis of drug and administrative costs allowed by U.S. Private and public third-party payers for 3 intravenous biologic agents for rheumatoid arthritis.
Wong BJ; Cifaldi MA; Roy S; Skonieczny DC; Stavrakas S
J Manag Care Pharm; 2011 May; 17(4):313-20. PubMed ID: 21534642
[TBL] [Abstract][Full Text] [Related]
29. Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis.
Franke LC; Ament AJ; van de Laar MA; Boonen A; Severens JL
Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S118-23. PubMed ID: 19822057
[TBL] [Abstract][Full Text] [Related]
30. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
[TBL] [Abstract][Full Text] [Related]
31. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
[TBL] [Abstract][Full Text] [Related]
32. The effect of health related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: a longitudinal analysis.
Ethgen O; Kahler KH; Kong SX; Reginster JY; Wolfe F
J Rheumatol; 2002 Jun; 29(6):1147-55. PubMed ID: 12064827
[TBL] [Abstract][Full Text] [Related]
33. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
Joyce AT; Smith P; Khandker R; Melin JM; Singh A
J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
[TBL] [Abstract][Full Text] [Related]
34. [Social costs of the most common inflammatory rheumatic diseases in Mexico from the patient's perspective].
Mould-Quevedo J; Peláez-Ballestas I; Vázquez-Mellado J; Terán-Estrada L; Esquivel-Valerio J; Ventura-Ríos L; Aceves-Avila FJ; Bernard-Medina AG; Goycochea-Robles MV; Hernández-Garduño A; Burgos-Vargas R; Shumski C; Garza-Elizondo M; Ramos-Remus C; Espinoza-Villalpando J; Alvarez-Hernández E; Flores-Alvarado D; Rodríguez-Amado J; Casasola-Vargas J; Skinner-Taylor C;
Gac Med Mex; 2008; 144(3):225-31. PubMed ID: 18714591
[TBL] [Abstract][Full Text] [Related]
35. Direct costs related to rheumatoid arthritis: the patient perspective.
Hülsemann JL; Mittendorf T; Merkesdal S; Handelmann S; von der Schulenburg JM; Zeidler H; Ruof J
Ann Rheum Dis; 2005 Oct; 64(10):1456-61. PubMed ID: 15800007
[TBL] [Abstract][Full Text] [Related]
36. Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?
Eriksson JK; Johansson K; Askling J; Neovius M
Ann Rheum Dis; 2015 Apr; 74(4):648-54. PubMed ID: 24323395
[TBL] [Abstract][Full Text] [Related]
37. Direct healthcare costs and predictors of costs in patients with primary Sjogren's syndrome.
Callaghan R; Prabu A; Allan RB; Clarke AE; Sutcliffe N; Pierre YS; Gordon C; Bowman SJ;
Rheumatology (Oxford); 2007 Jan; 46(1):105-11. PubMed ID: 16728437
[TBL] [Abstract][Full Text] [Related]
38. 28-Joint count disease activity score at 3 months after diagnosis of early rheumatoid arthritis is strongly associated with direct and indirect costs over the following 4 years: the Swedish TIRA project.
Hallert E; Husberg M; Skogh T
Rheumatology (Oxford); 2011 Jul; 50(7):1259-67. PubMed ID: 21292734
[TBL] [Abstract][Full Text] [Related]
39. Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
Wolfe F; Michaud K; Choi HK; Williams R
J Rheumatol; 2005 Oct; 32(10):1875-83. PubMed ID: 16206340
[TBL] [Abstract][Full Text] [Related]
40. Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis.
Clarke AE; Levinton C; Joseph L; Penrod J; Zowall H; Sibley JT; Grover SA; Esdaile JM
J Rheumatol; 1999 May; 26(5):1068-75. PubMed ID: 10332970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
